Lumosa Therapeutics Co., Ltd. (TPEX: 6535)

Lumosa Therapeutics Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 19, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	61,437	11,268	6,425	6,117	5,194	4,042
Market Cap Growth	436.43%	75.37%	5.04%	17.77%	28.50%	38.16%
Enterprise Value	60,912	10,380	5,254	4,757	4,625	3,201
Last Close Price	372.50	68.15	39.31	40.16	35.03	34.18
PE Ratio	-	-	-	63.75	-	-
PS Ratio	1443.67	197.97	241.17	352.32	239.89	23.49
PB Ratio	52.55	7.89	3.85	2.89	3.28	3.86
P/TBV Ratio	47.31	8.05	4.01	2.95	3.68	4.76
EV/Sales Ratio	1428.48	182.37	197.19	273.96	213.59	18.61
Debt / Equity Ratio	0.01	0.01	0.00	0.01	0.01	0.01
Asset Turnover	0.02	0.03	0.01	0.01	0.01	0.13
Inventory Turnover	0.14	0.15	0.13	0.13	0.30	2.38
Quick Ratio	2.96	3.98	5.65	6.60	6.83	3.41
Current Ratio	3.74	4.75	6.44	7.23	7.07	3.52
Return on Equity (ROE)	-29.64%	-16.16%	-26.63%	5.18%	-24.54%	-20.78%
Return on Assets (ROA)	-14.04%	-13.26%	-9.03%	-13.01%	-13.73%	-6.89%
Return on Capital (ROIC)	-16.00%	-15.08%	-10.05%	-14.42%	-16.07%	-8.04%
Earnings Yield	-0.65%	-2.11%	-7.70%	1.57%	-6.21%	-5.96%
FCF Yield	-0.45%	-3.04%	-4.71%	-7.40%	-2.50%	-9.39%
Buyback Yield / Dilution	0.50%	-0.03%	-7.61%	-24.92%	-3.01%	-18.59%
Total Shareholder Return	0.50%	-0.03%	-7.61%	-24.92%	-3.01%	-18.59%

Source: S&P Capital IQ. Standard template. Financial Sources.